Literature DB >> 3896368

Long-term follow-up after transurethral prostatic resection with or without a short peri-operative antibiotic course.

M Grabe, S Hellsten.   

Abstract

This study was undertaken to analyse the results in 192 patients who 3 to 4 years earlier had undergone transurethral resection (TUR) in a controlled clinical trial on the value of a short peri-operative course of antibiotics. The survival rate was comparable in both groups. Most deaths were due to cardiovascular disease and/or cancer of the prostate and the gastrointestinal tract. Infectious events predominated in the control group and more antibiotics were prescribed for these patients during follow-up than for the patients in the peri-operative antibiotic group. Bacteriuria was found in 24% of patients, evenly distributed between the groups. Eighty-three per cent were satisfied with the results of prostatectomy but 38% complained of symptoms from the lower urinary tract. The maximum urinary flow rate was not influenced by the presence of bacteriuria and/or symptoms. There was no difference between the groups regarding mortality or morbidity except for the frequency of post-operative urethral stricture formation, which was significantly higher in the controls. It was concluded that prospective long-term follow-up is indicated to assess the effect of short peri-operative antibiotic courses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896368     DOI: 10.1111/j.1464-410x.1985.tb06307.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

Review 1.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

Review 2.  Antimicrobial prophylaxis in transurethral surgery.

Authors:  P O Madsen; P H Graversen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

3.  Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery.

Authors:  M Grabe; A Forsgren; T Björk; S Hellsten
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.